Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY-NC-NDCellular and molecular life sciences : CMLS

Bacterial stimulation triggers IRF7-mediated IFN-λ production in hepatocytes to attenuate sepsis

  1. 1Chongqing, 400042 China
  2. 2Chongqing, 400038 China

Abstract

Interferon lambda (IFN-λ) is produced early by hematopoietic or epithelial cells and acts as a primary mediator of frontline antiviral defense without inducing inflammatory responses. However, whether hepatocytes, rather than immune cells, can secrete IFN-λs to protect against bacterial infection remains unestablished. Here, we demonstrate that hepatocytes secrete IFN-λs in response to bacterial stimulation both in vivo and in vitro, and that this secreted IFN-λs directly inhibits bacterial proliferation. Mechanistically, during in vitro bacterial infection, the upregulation and activation of the transcription factor IRF7 drive type III interferon (IFN-λ) production in hepatocytes through a cascading TLR4 signaling pathway, rather than via RIG-I or MDA5. Importantly, pretreatment with IFN-λs, through interaction with IFNLR1 in hepatocytes, increases the number of dead bacteria, improves systemic outcomes, and enhances survival in septic mice. Furthermore, sepsis patients show increased expression levels of IRF7, IFN-λ2, and IFN-λ3. These findings reveal that IFN-λs function as active mediators against bacterial infection, eliciting a unique antibacterial response to eliminate bacteria. This work further suggests that enhancing IFN-λs production in hepatocytes could serve as a potential therapeutic strategy for sepsis.

Related

  1. Negative Word Production in Bilinguals Triggers Inhibitory Mechanisms: Evidence from Mass Univariate Time-Frequency Analysis
    Rafał Jończyk, Marcin Naranowicz, Guillaume Thierry
    PsyArXivPreprintCC BY 4.0Full textNeurosciencePhysiologyOSF
  2. Recombinant bacterial β-galactosidases for lactose bioconversion and galacto-oligosaccharide production: a comparative overview
    Anel Kostanova, Yuliya Shamsiyeva, Zhiger Akishev +2
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textSystems & synthetic biologyPMCCrossrefEurope PMC
  3. Prevalence, bacterial etiology, and risk factors of clinical and subclinical mastitis in dromedary camels (Camelus dromedarius) across pastoral and peri-urban production systems in south-central Somalia.
    Shafii Abdullahi Mohamed, Daha Hussein Mumin, Anfac Abdullahu Guled +4
    BMC veterinary researchPeer-reviewedCC BYFull textPlant biologyEurope PMCPMC
  4. Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury
    Rita Manco, Laure-Alix Clerbaux, Stefaan Verhulst +9
    Journal of HepatologyPeer-reviewedLicence not statedFull text92 citedGeneral biologyHAL
  5. Attenuation of Heparan Sulfate Proteoglycan Binding Enhances In Vivo Transduction of Human Primary Hepatocytes with AAV2
    Marti Cabanes-Creus, Adrian Westhaus, Renina Gale Navarro +17
    Molecular Therapy - Methods and Clinical DevelopmentPeer-reviewedCC BYFull text47 citedGenetics & genomicsHAL
BibTeX
@article{ma2026bacterial,
  title = {{Bacterial stimulation triggers IRF7-mediated IFN-λ production in hepatocytes to attenuate sepsis}},
  author = {Wei Ma and Junjie Shu and Wanqi Tang and Haoru Liu and Hao Zhang and Xue Yang and Qiangguo Gao and Huaping Liang and Xia Yang},
  journal = {Cellular and molecular life sciences : CMLS},
  year = {2026},
  month = jul,
  doi = {10.1007/s00018-026-06351-6},
  url = {https://europepmc.org/article/PMC/PMC13691052},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Bacterial stimulation triggers IRF7-mediated IFN-λ production in hepatocytes to attenuate sepsis
AU  - Wei Ma
AU  - Junjie Shu
AU  - Wanqi Tang
AU  - Haoru Liu
AU  - Hao Zhang
AU  - Xue Yang
AU  - Qiangguo Gao
AU  - Huaping Liang
AU  - Xia Yang
PY  - 2026
DA  - 2026/07/01
JO  - Cellular and molecular life sciences : CMLS
DO  - 10.1007/s00018-026-06351-6
UR  - https://europepmc.org/article/PMC/PMC13691052
AB  - Interferon lambda (IFN-λ) is produced early by hematopoietic or epithelial cells and acts as a primary mediator of frontline antiviral defense without inducing inflammatory responses. However, whether hepatocytes, rather than immune cells, can secrete IFN-λs to protect against bacterial infection remains unestablished. Here, we demonstrate that hepatocytes secrete IFN-λs in response to bacterial stimulation both in vivo and in vitro, and that this secreted IFN-λs directly inhibits bacterial proliferation. Mechanistically, during in vitro bacterial infection, the upregulation and activation of the transcription factor IRF7 drive type III interferon (IFN-λ) production in hepatocytes through a cascading TLR4 signaling pathway, rather than via RIG-I or MDA5. Importantly, pretreatment with IFN-λs, through interaction with IFNLR1 in hepatocytes, increases the number of dead bacteria, improves systemic outcomes, and enhances survival in septic mice. Furthermore, sepsis patients show increased expression levels of IRF7, IFN-λ2, and IFN-λ3. These findings reveal that IFN-λs function as active mediators against bacterial infection, eliciting a unique antibacterial response to eliminate bacteria. This work further suggests that enhancing IFN-λs production in hepatocytes could serve as a potential therapeutic strategy for sepsis.
SN  - 1420-682X
SN  - 1420-9071
ER  -